These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38773764)

  • 1. The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression.
    Uysal C; Koyuncu S; Ipekten F; Karakukcu C; Kocyigit I
    Ther Apher Dial; 2024 Oct; 28(5):760-768. PubMed ID: 38773764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Urinary Neutrophil Gelatinase-Associated Lipocalin for Predicting the Severity of Renal Functions in Patients With Autosomal-Dominant Polycystic Kidney Disease.
    Vareesangthip K; Vareesangthip K; Limwongse C; Reesukumal K
    Transplant Proc; 2017 Jun; 49(5):950-954. PubMed ID: 28583565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma NGAL and ADPKD progression].
    Virzì GM; Gastaldon F; Corradi V; de Cal M; Cruz DN; Clementi M; Ronco C
    G Ital Nefrol; 2015; 32(3):. PubMed ID: 26093138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials.
    Wang W; You Z; Steele CN; Gitomer B; Chonchol M; Nowak KL
    BMC Nephrol; 2024 Jun; 25(1):206. PubMed ID: 38918734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
    Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
    Chonchol M; Gitomer B; Isakova T; Cai X; Salusky I; Pereira R; Abebe K; Torres V; Steinman TI; Grantham JJ; Chapman AB; Schrier RW; Wolf M
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1461-1469. PubMed ID: 28705885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary biomarkers at early ADPKD disease stage.
    Petzold K; Poster D; Krauer F; Spanaus K; Andreisek G; Nguyen-Kim TD; Pavik I; Ho TA; Serra AL; Rotar L
    PLoS One; 2015; 10(4):e0123555. PubMed ID: 25875363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and Urine Neutrophil Gelatinase-Associated Lipocalin Levels Measured at Admission Predict Progression to Chronic Kidney Disease in Sepsis-Associated Acute Kidney Injury Patients.
    Tuan PNH; Quyen DBQ; Van Khoa H; Loc ND; Van My P; Dung NH; Toan ND; Quyet D; Thang LV
    Dis Markers; 2020; 2020():8883404. PubMed ID: 32908617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
    Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
    J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Campo S; Fazio MR; Nicocia G; Buemi M
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):337-44. PubMed ID: 19176795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fasting during the month of Ramadan on renal function in patients with autosomal dominant polycystic kidney disease
.
    Ekinci I; Erkoc R; Gursu M; Dogan EE; Kilic E; Cebeci E; Ozturk S; Kazancioglu R
    Clin Nephrol; 2018 Feb; 89(2):103-112. PubMed ID: 29035195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease.
    Bolignano D; Coppolino G; Campo S; Aloisi C; Nicocia G; Frisina N; Buemi M
    Am J Nephrol; 2007; 27(4):373-8. PubMed ID: 17570904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
    Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
    Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.
    Liu Y; Li HX; Ying ZW; Guo JJ; Cao CY; Jia W; Yang HR
    Clin Lab; 2016; 62(1-2):155-63. PubMed ID: 27012045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.